Biologics Regulatory Spine Top Stories Cerapedics’ PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use byTim AllenJanuary 13, 2026
Biologics Spine Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft byTim AllenDecember 17, 2025
Biologics Spine Sports Medicine Top Stories Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft byTim AllenDecember 11, 2025
Biologics Acuitive Technologies introduces Citregraft, a unique bone graft substitute designed to bind proteins and enhance regeneration byTim AllenNovember 26, 2025
Biologics Spine Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval byTim AllenJuly 8, 2025
Regulatory Spine Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion byJosh SandbergJune 23, 2025
Biologics Spine Top Stories Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance byJosh SandbergApril 23, 2025
Biologics Regulatory Spine Ventris Medical Receives Additional FDA Clearance for Backpack® Bone Graft in the Intervertebral Disc Space byJosh SandbergApril 8, 2025
Regulatory Top Stories SurGenTec® Breaks New Ground with FDA Clearance for OsteoFlo® HydroFiber™, Receives Indication for Stand-Alone Use Equivalent to Autograft byJosh SandbergJanuary 16, 2025
Biologics Regulatory Top Stories Ventris Medical Receives 510(k) Clearance for Innovative Backpack® Bone Graft Containment System byJosh SandbergJanuary 9, 2025
